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Purpose: To determine the prevalence of the spot sign and the ac-
curacy of using the spot sign to predict intracerebral hem-
orrhage (ICH) expansion with standardized multiphase 
computed tomographic (CT) angiography.
Materials and 
Methods:
This prospective observational cohort study included 123 
consecutive patients with acute ICH (onset ,6 hours). 
Patients underwent multiphase CT angiography in three 
automated phases after injection of contrast material. Pa-
tients were classified as having one of four patterns (pat-
tern A, B, C, or D) according to the presence of the spot 
sign in the three phases. Pattern A was the more arte-
rial pattern, and pattern D was the more venous pattern. 
Ninety-five patients underwent follow-up unenhanced CT 
24 hours after symptom onset. Primary outcome was sub-
stantial hematoma expansion (.33% or .6 mL) at 24 
hours. Associations between the presence of the spot sign 
and substantial hematoma expansion were assessed by us-
ing the Pearson x2 test.
Results: The later the phase of CT angiography, the higher the 
frequency of the spot sign. The spot sign was seen in 29.3% 
of patients in phase 1, 43.1% of patients in phase 2, and 
46.3% of patients in phase 3 (P , .001). The presence of 
the spot sign in any phase was related to substantial he-
matoma expansion (P , .001 for all comparisons; Bonfer-
roni adjusted a = .0125), with highest positive predictive 
value in phase 1 (64.0%) and highest negative predictive 
value in phase 2 (90.2%). The more arterial the pattern 
of spot sign presentation, the greater the frequency of 
substantial hematoma expansion (P = .013). Absolute he-
matoma growth analysis revealed a hierarchical pattern of 
spot sign presentations, as follows: A . B . C . D . no 
spot sign (P = .002).
Conclusion: Multiphase CT angiography can help differentiate among 
different forms of spot sign presentation and can help 
stratify patients at risk for hematoma expansion. The 
more arterial the spot sign pattern, the greater the 
frequency and extent of expansion.
q RSNA, 2017
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additional radiation exposure (15–17). 
We hypothesized that the more arterial 
the pattern of spot sign presentation, 
the greater the frequency and extent 
of hematoma expansion. Secondarily, 
we aimed to determine the prevalence 
of the spot sign by using multiphase CT 
angiography and to investigate whether 
multiphase CT angiography can provide 
additional information on the underlying 
pathophysiology of the spot sign.
Materials and Methods
Study Design
We conducted a single-center, pro-
spective, observational cohort study of 
consecutive patients aged 18 years and 
older with a symptomatic and radiolog-
ically confirmed ICH who underwent 
scanning within 6 hours from symptom 
onset during a 40-month period (April 
1, 2013, to July 31, 2016). Exclusion cri-
teria included known secondary cause 
of ICH, deep coma (defined as a score 
of 3–5 on the Glasgow coma scale), 
known contraindication to CT angiog-
raphy (eg, renal failure or allergy to 
iodinated contrast material), and lack 
of informed consent. Patients or next 
of kin gave written informed consent. 
The local ethics committee approved all 
aspects of the study protocol.
Predicting Hematoma Growth and Out-
come in Intracerebral Hemorrhage Us-
ing Contrast Bolus CT (PREDICT) study 
validated the spot sign as a predictor 
of hematoma expansion in patients 
scanned within 6 hours of ICH onset, 
and those researchers recommended it 
as an entry criterion for hemostatic tri-
als (6). However, the sensitivity of the 
spot sign in the prediction of substan-
tial hematoma expansion with use of 
single-phase CT angiography was 51% 
in the PREDICT study (6). In a post 
hoc analysis of the PREDICT study, 
researchers hypothesized that the low 
sensitivity observed was likely due to 
variability in timing of image acquisition 
after the administration of the bolus of 
contrast material and suggested that 
the frequency and diagnostic yield of 
the spot sign may differ among phases 
of CT angiography acquisition (10).
Several studies have suggested that 
the introduction of a delay after the ad-
ministration of a bolus of contrast ma-
terial can increase the sensitivity of the 
CT angiography spot sign in the predic-
tion of hematoma expansion (11–14). 
However, these studies analyzed retro-
spectively collected data, and most of 
them did not have standardized indica-
tions for CT angiography or fixed timing 
for the delayed imaging (11–14). Thus, 
there is currently no accepted consen-
sus on the timing of CT angiography. 
Furthermore, the pathophysiologic sig-
nificance of the spot sign remains un-
known, which adds uncertainty about 
the optimal timing for the acquisition of 
CT angiograms.
The primary aim of this study was to 
determine the accuracy of the spot sign 
in the prediction of hematoma expan-
sion in patients with acute ICH by using 
standardized multiphase CT angiogra-
phy. This technique enables the demon-
stration of additional time points from 
CT angiography by using the same injec-
tion of contrast material and very little 
https://doi.org/ 10.1148/radiol.2017162839.
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Advances in Knowledge
 n Multiphase CT angiography can 
acquire temporal information of 
the spot sign without the require-
ment of additional contrast 
material.
 n The later the phase of multiphase 
CT angiography, the higher the 
frequency of the spot sign 
(29.3% in phase 1, 43.1% in 
phase 2, and 46.3% in phase 3; 
P , .001).
 n Predictive values of the spot sign 
for substantial hematoma expan-
sion vary across phases of multi-
phase CT angiography; the high-
est positive predictive value is 
observed in phase 1 (64.0%), 
and the highest negative predic-
tive value is observed in phase 2 
(90.2%).
 n Multiphase CT angiography can 
help define predictive patterns 
from spot sign presentation, 
from pattern A (with highest 
degree of hematoma expansion) 
to pattern D and absence of spot 
sign (with lowest degrees of he-
matoma expansion) (P = .002).
Implication for Patient Care
 n Multiphase CT angiography can 
be used to predict hematoma 
expansion in patients with acute 
intracerebral hemorrhage.
Hematoma expansion is a potentially modifiable determinant of poor outcome in acute intracerebral 
hemorrhage (ICH) (1,2) and represents 
a key target for emerging therapies (3). 
Hemostatic therapy trials with recombi-
nant factor VIIa have demonstrated re-
ductions in hematoma expansion with-
out improvement in clinical outcomes 
(4), presumably because of the inclu-
sion of a majority of patients unlikely to 
experience hematoma expansion and, 
therefore, to benefit from hemostatic 
therapy (5,6). Hence, the success of fu-
ture interventions aimed at preventing 
hematoma expansion and subsequent 
poor outcome will likely depend on the 
accurate selection of patients at risk for 
hematoma expansion (6,7).
The computed tomographic (CT) 
angiography spot sign is a focus of con-
trast material enhancement within an 
ICH that is visible on the source im-
ages from CT angiography (8,9). The 
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(8,21,22). A secondary outcome was 
absolute volumetric hematoma growth.
Statistical Analysis
Statistical analysis was performed by us-
ing software (SPSS, version 17.0; IBM, 
Chicago, Ill). The categorical variables 
are presented as absolute values (with 
percentages) and the continuous var-
iables as means 6 standard deviation 
or medians (with interquartile ranges 
[IQRs]). Statistical significance for inter-
group differences was assessed by using 
the Pearson x2 or Fisher exact test for 
categorical variables and the Student t 
test, Mann-Whitney U test, or Kruskal-
Wallis test for continuous variables, 
as appropriate. Significant differences 
among the three phases of multiphase 
CT angiography were assessed with the 
Cochran Q test for the frequency of the 
spot sign and with the Friedman test 
(nonparametric repeated-measurements 
analysis of variance) for the radiologic 
characteristics of the spot sign. The sen-
sitivity, specificity, predictive values, ac-
curacy, and area under the curve of the 
spot sign in the three different phases of 
multiphase CT angiography for the pre-
diction of substantial hematoma expan-
sion were calculated.
Multiple logistic regression analyses 
were used to test for the association 
of the spot sign in different phases of 
CT angiography with substantial hema-
toma expansion; analyses were adjusted 
for the covariates age, sex, anticoagu-
lant use, baseline National Institutes of 
Health Stroke Scale score, time from 
symptom onset to baseline CT (onset 
to imaging time), baseline ICH volume, 
and intraventricular extension. The sam-
ple size did not permit the determina-
tion of covariates that were associated 
with outcomes. Results are presented 
as odds ratios and 95% confidence in-
tervals. Two-sided P , .05 was consid-
ered to indicate a statistically significant 
difference. The Bonferroni method was 
applied to the results of multiple com-
parison tests (hematoma expansion vs 
presence of spot sign in phase 1, phase 
2, phase 3, or any phase). After Bonfer-
roni correction, the adjusted significance 
level for multiple comparisons was a of 
.0125 (0.05/4 = 0.0125).
volumetric analysis and who was blind-
ed to the multiphase CT angiographic 
scans and spot sign status prospec-
tively evaluated baseline and follow-up 
unenhanced CT scans. ICH volumes 
were measured by using semiautomatic 
Hounsfield unit, threshold-based, com-
puterized planimetry software (Syngo, 
Siemens). ICH location (cerebral lobes, 
basal ganglia or thalamus, brainstem, 
or cerebellum), intraventricular exten-
sion, and subarachnoid extension were 
recorded.
A neuroradiologist (P.C.) with 
more than 5 years of experience in the 
analysis of spot signs at CT angiogra-
phy, and who was blinded to follow-up 
unenhanced CT scans and clinical out-
comes, independently interpreted mul-
tiphase CT angiographic scans. The 
spot sign was defined according to pre-
viously established criteria (18). The 
presence and radiologic characteristics 
of the spot sign, including total number 
of spot signs, maximum attenuation (in 
Hounsfield units), and maximum axial 
diameter, were recorded in each phase 
of multiphase CT angiography. Patients 
who were positive for the spot sign 
were prospectively categorized into one 
of four predefined patterns of spot sign 
presentation (Fig 1), as follows: Pa-
tients with spot sign present in phase 
1 were classified as having pattern A if 
the spot sign was not present in phase 
3 or as having pattern B if the sign was 
also present in phase 3; patients with-
out spot sign in phase 1 were classified 
as having pattern C if the sign was pre-
sent in phase 2 or as having pattern D 
if the sign was present only in phase 3. 
Patterns of spot sign presentation were 
prospectively defined; the intent was to 
represent the dynamic course of spot 
signs, from spots that resolve quickly 
to spots that appear late, as observed 
in studies of dynamic CT angiography 
(19,20).
Outcomes
The primary outcome was substantial 
hematoma expansion at follow-up CT, 
defined as an absolute volumetric ICH 
growth of more than 6 mL or relative 
volumetric ICH enlargement of more 
than 33% from that at baseline CT 
Data Acquisition
On admission, we recorded relevant 
demographic characteristics, medical 
history, clinical presentation, neurologic 
status (National Institutes of Health 
Stroke Scale and Glasgow Coma Scale 
scores), and results of routine labora-
tory tests. Time from symptom onset 
was defined as time of first symptoms or 
signs of neurologic deficits or the time 
the patient was last known to be neuro-
logically intact. All patients underwent a 
standardized acute ICH evaluation at our 
institution that included unenhanced CT 
followed by multiphase CT angiography 
at baseline (,6 hours) and unenhanced 
follow-up CT at approximately 24 hours 
(range, 22–30 hours).
All CT examinations were per-
formed from the skull base to the vertex 
with a multi–detector row CT scanner 
(Somatom Definition AS; Siemens, Er-
langen, Germany). Images were ac-
quired with 1.0-mm-thick sections for 
unenhanced CT and with 0.6-mm-thick 
sections for multiphase CT angiogra-
phy. Multiphase CT angiography was 
performed in three automated phases 
after intravenous injection of contrast 
material. The first phase acquisition was 
timed to occur during the peak arterial 
phase, the second during the equilibrium 
and/or peak venous phase, and the third 
during the late venous phase (10). The 
first phase was triggered by monitoring 
the bolus of contrast material from the 
descending aorta; scanning started 8 
seconds after the CT attenuation value 
of the aorta reached the threshold value 
of 120 HU. The second phase was ac-
quired after a delay of 4 seconds, and 
the third phase after a delay of 15 sec-
onds. Scanning duration of each phase 
was 3.5 seconds, with an average dose-
length product of 300–350 mGy · cm 
per phase. A total of 80 mL of contrast 
material (65.2% iodixanol, Visipaque 
320; GE Healthcare, Oslo, Norway) was 
injected at a rate of 5 mL/sec; this was 
followed by a 30-mL normal saline chase 
at a rate of 6 mL/sec.
Image Analysis
A stroke neurologist (D.R.L.) with 
more than 5 years of experience in CT 
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and baseline imaging was 159 minutes 
(IQR, 87–234 minutes).
Hematoma expansion analysis was 
limited to 95 patients after the exclusion 
of two patients who underwent surgical 
hematoma evacuation and 26 patients 
who did not undergo follow-up CT (20 
because of death and six because of 
withdrawal of care within the first 24 
hours) (Fig 2). Patients not included in 
the hematoma expansion analysis were 
more likely to be older and have lower 
Glasgow Coma Scale scores, higher Na-
tional Institutes of Health Stroke Scale 
score and ICH volume, a lobar ICH 
location, intraventricular or subarach-
noid extension, and spot sign (Table 2).
Spot Sign Frequency
Overall, 62 of the 123 patients (50.4%) 
had the spot sign in at least one phase. 
The spot sign was seen more frequently 
in the later phases of multiphase CT 
angiography: in 36 of 123 patients 
(29.3%) in phase 1, 53 of 123 (43.1%) 
in phase 2, and 57 of 123 (46.3%) in 
phase 3 (P , .001). Radiologic charac-
teristics of the spot sign according to 
the different phases of multiphase CT 
angiography are summarized in Table 3. 
Spot sign characteristics varied across 
phases: The later the phase of multi-
phase CT angiography, the higher the 
total number and maximum axial di-
ameter and the lower the maximum 
attenuation.
Pattern A was observed in three of 
the 62 patients with the spot sign in at 
least one phase (4.8%); pattern B, in 
33 (53.2%); pattern C, in 18 (29.0%); 
and pattern D, in eight (12.9%). There 
was no significant difference in the time 
between onset to baseline imaging with 
respect to the more arterial pattern (P 
= .523) (Fig 3).
Substantial Hematoma Expansion
Among the 95 patients included in the he-
matoma expansion analysis, 41 (43.2%) 
had a spot sign in at least one phase and 
25 (26.3%) experienced substantial he-
matoma expansion (.6 mL or .33%). 
Substantial hematoma expansion oc-
curred more frequently in patients with 
spot sign in phase 1 (16 of 25 patients 
[64.0%] vs nine of 70 patients [12.9%]; 
multiphase CT angiography within 6 
hours from symptom onset (Fig 2). 
Baseline characteristics are provided 
in Table 1. The median ICH volume 
was 16.7 mL (IQR, 5.8–44.3 mL), 
and the median time between onset 
Results
Study Population
A total of 123 patients were included in 
the study, all of whom had undergone 
Figure 1
Figure 1: Representative images from CT angiography show the four patterns of spot sign presentation (patterns 
A, B, C, and D) according to presence of spot sign (arrows) in the three phases of multiphase CT angiography.
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outcome remained significant in sepa-
rate adjusted multiple logistic regression 
models.
Absolute Hematoma Growth
The median absolute hematoma growth 
at 24 hours was 0.6 mL (IQR, 0.0–4.6 
mL). The presence of the spot sign was 
associated with higher absolute hema-
toma growth in phase 1 (8.4 mL [IQR, 
0.1–28.9 mL] vs 0.4 mL [IQR, 0.0–1.7 
mL]; P = .001), phase 2 (5.2 mL [IQR, 
0.1–17.7 mL] vs 0.3 mL [IQR, 0.0–1.1 
mL]; P , .001), and phase 3 (2.8 mL 
[IQR, 0.0–16.7 mL] vs 0.4 mL [IQR, 
0.0–1.7 mL]; P = .008), as well in any 
of the three phases (4.0 mL [IQR, 0.0–
16.3 mL] vs 0.3 mL [IQR, 0.0–1.0 mL]; 
P = .001), compared with patients with-
out the spot sign (Bonferroni adjusted 
a = .0125). Absolute hematoma growth 
analysis revealed a hierarchical pattern 
of spot sign presentation and hema-
toma growth, as follows: pattern A . 
pattern B . pattern C . pattern D . 
no spot sign (P = .002) (Fig 3).
Discussion
The results of this study demonstrate 
that the more arterial the pattern of 
spot sign presentation, the greater the 
frequency and extent of ICH expansion. 
Furthermore, the frequency of the spot 
sign varies across phases of multiphase 
CT angiography, being higher in the later 
phases. The results of our study also 
suggest that the different patterns of 
spot sign presentation in multiphase CT 
angiography may reflect the pathophys-
iologic course of ICH expansion, from 
active hemorrhage to resolved bleeding.
Multiphase CT angiography is an 
emerging vascular imaging technique 
that has recently been introduced for 
the evaluation of acute ischemic stroke 
(16,23,24). In acute ICH, multiphase CT 
angiography can acquire temporal in-
formation of the spot sign at three data 
points without the requirement of addi-
tional contrast material and with mini-
mal additional radiation over that with 
single-phase CT angiography (15,17). 
Several CT modalities were previously 
proposed for the evaluation of the spot 
sign in the prediction of hematoma 
Predictive values varied depending 
on the acquisition phase (Table 4): Al-
though the highest positive predictive 
value was observed in phase 1 (64.0% 
[16 of 25 patients]), negative predictive 
values were consistently high in all phas-
es; the negative predictive value was 
highest in phase 2 (90.2% [55 of 61 pa-
tients]) of multiphase CT angiography. 
The association of spot sign presence 
in phase 1 (odds ratio, 8.1; 95% confi-
dence interval: 2.5, 25.9), phase 2 (odds 
ratio, 8.2; 95% confidence interval: 2.6, 
25.8), phase 3 (odds ratio, 5.0; 95% 
confidence interval: 1.7, 15.2), or any 
phase (odds ratio, 6.5; 95% confidence 
interval: 2.0, 21.0) with the primary 
P , .001), phase 2 (19 of 34 patients 
[55.9%] vs six of 61 patients [9.8%]; P 
, .001), and phase 3 (17 of 36 patients 
[47.2%] vs eight of 59 patients [13.6%]; 
P = .001) than in patients without spot 
sign in these phases, as well as in patients 
with spot sign in any of the three phases 
(20 of 41 patients [48.8%] vs five of 54 
patients [9.3%]; P , .001) (Bonferroni 
adjusted a = .0125). The more arterial 
the pattern of spot sign presentation, the 
higher the frequency of substantial hema-
toma expansion: 100% (three of three 
patients) in pattern A, 59.1% (13 of 22 
patients) in pattern B, 40% (four of 10 
patients) in pattern C, and 0% (zero of 
six patients) in pattern D (P = .013).
Figure 2
Figure 2: Cohort flowchart. CTA = CT angiography, GCS = Glasgow Coma Scale.
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(31,32). Multiphase CT angiography 
has advantages over CT perfusion and 
dynamic CT angiography, providing dy-
namic information about the spot sign 
in a faster and easier manner at a lower 
dose of radiation and contrast material 
(16). Multiphase CT angiography may 
resolve the need for standardization 
of CT angiography raised by previous 
studies of contrast-enhanced CT and 
delayed CT angiography.
Our study demonstrates that the 
later the phase of multiphase CT an-
giography, the higher the frequency 
of the spot sign in patients with acute 
ICH who systematically underwent a 
standardized automated multiphase CT 
angiography protocol with fixed timing 
for image acquisitions. Nearly half of 
patients who had the spot sign at one 
angiography (8,11–14,25,26,28), which 
limits their generalizability, and did not 
use fixed timing for the delayed imaging 
(11–14,26–28), which may have altered 
the ability to detect some spot signs.
Other CT technologies allow for dy-
namic contrast imaging over 1 minute 
or longer, producing CT perfusion and 
dynamic CT angiographic images that 
provide information about the dynamic 
changes of the spot sign (28–32). CT 
perfusion studies have also reported an 
increase of both spot sign detection and 
its sensitivity in the prediction of he-
matoma expansion compared with that 
of single-phase CT angiography, but 
with incomplete spatial coverage of ICH 
volume (29,30). Conversely, studies of 
dynamic CT angiography did not at-
tempt to predict hematoma expansion 
expansion apart from single-phase CT 
angiography (6,8,9), including contrast 
material–enhanced CT, delayed CT an-
giography, CT perfusion, and dynamic 
CT angiography (8,11–14,25–32). How-
ever, there is no accepted consensus 
for CT technique or timing of image 
acquisitions. Studies that introduced 
second-pass imaging after the initial ad-
ministration of a bolus of contrast mate-
rial, termed postcontrast CT or delayed 
CT angiography in the literature, have 
shown divergent results; overall, how-
ever, these studies suggest that second-
pass imaging can increase both spot sign 
detection and its sensitivity for predict-
ing hematoma expansion compared with 
first-pass CT angiography (8,11–14,25–
28). However, most of these studies did 
not have standardized indications for CT 
Table 1
Summary of Baseline Characteristics according to the Presence of the Spot Sign in Any Phase of Multiphase CT Angiography
Variable All Patients (n = 123) Patients with Spot Sign (n = 62) Patients without Spot Sign (n = 61) P Value*
Age (y) 72.0 6 13.5 76.6 6 11.0 67.2 6 14.2 ,.001
Men† 79 (64.2) 34 (54.8) 45 (73.8) .029
Antiplatelet use† 35 (28.5) 22 (35.5) 13 (21.3) .082
Anticoagulant use† 21 (17.1) 15 (24.2) 6 (9.8) .034
GCS score‡ 15 (14–15) 14 (13–15) 15 (14–15) .002
NIHSS score‡ 16 (8–20) 18 (14–21) 10 (6–17) ,.001
Blood pressure (mm Hg)
 Systolic 172.7 6 32.7 175.3 6 33.8 170.1 6 31.6 .385
 Diastolic 90.3 6 19.8 91.3 6 21.1 89.3 6 18.6 .595
Glucose level (mmol/L) 8.2 6 3.0 8.7 6 3.4 7.7 6 2.4 .190
Creatinine level (mmol/L) 78.4 6 22.6 78.1 6 21.2 78.6 6 24.1 .912
Hemoglobin (g/L) 138.7 6 20.3 134.8 6 20.9 142.4 6 19.2 .044
Leukocyte count (3103 cells/mL) 9.9 6 4.1 10.1 6 4.4 9.8 6 3.8 .702
Platelet count (3103 cells/mL) 223.1 6 71.9 224.9 6 81.9 221.4 6 61.7 .793
INR 1.27 6 0.61 1.43 6 0.76 1.10 6 0.36 .019
aPTT (sec) 31.9 6 5.4 33.1 6 6.7 30.8 6 3.5 .022
Time between onset and imaging (min)‡ 159 (87–234) 135 (97–232) 184 (83–270) .489
ICH volume (mL)‡ 16.7 (5.8–44.3) 31.2 (13.7–62.7) 6.9 (3.7–21.3) ,.001
ICH location† .350
 Cerebral lobes 38 (30.9) 23 (37.1) 15 (24.6)
 Basal ganglia or thalamus 73 (59.3) 35 (56.5) 38 (62.3)
 Brainstem 5 (4.1) 2 (3.2) 3 (4.9)
 Cerebellum 7 (5.7) 2 (3.2) 5 (8.2)
Intraventricular extension† 50 (40.7) 37 (59.7) 13 (21.3) ,.001
Subarachnoid extension† 29 (23.6) 22 (35.5) 7 (11.5) .002
Note.—Except where indicated, data are means 6 standard deviations. aPTT = activated partial thromboplastin time, GCS = Glasgow Coma Scale, INR = international normalized ratio, NIHSS = 
National Institutes of Health Stroke Scale.
*P values were determined with the Pearson x2 test, Student t test, or Mann-Whitney U test as appropriate.
† Data are numbers of patients, with percentages in parentheses.
‡ Data are medians, with IQR in parentheses.
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on hematoma expansion and therefore 
cannot conclude that these statistically 
significant differences are clinically 
important.
The results of this study confirm 
that the yield of the spot sign in the pre-
diction of hematoma expansion varies 
across phases of multiphase CT angiog-
raphy. Although sensitivity and negative 
predictive value increased from phase 1 
to phase 2, specificity and positive pre-
dictive value were higher in phase 1 and 
decreased in subsequent phases. Mul-
tiphase CT angiography can therefore 
help stratify patients at risk for hema-
toma expansion in different decision-
making scenarios. A higher positive 
predictive value could help identify pa-
tients at higher risk for hematoma ex-
pansion and maximize the treatment ef-
fect in hemostatic trials (5). Conversely, 
a higher negative predictive value could 
help identify patients at lower risk for 
hematoma expansion, which could aid 
in avoiding intraoperative bleeding in 
surgical trials (33). At present, how-
ever, in the absence of treatments with 
consistently demonstrated effectiveness 
in acute ICH, multiphase CT angiogra-
phy cannot be recommended as stan-
dard clinical practice.
More arterial spot sign patterns 
were associated with more frequent 
and greater hematoma expansion. This, 
along with the different prevalence of 
the spot sign depending on the phase 
of acquisition, suggests that different 
forms of spot sign presentation repre-
sent different pathologic entities. Al-
though the general assumption is that 
the spot sign is a radiologic correlate of 
active bleeding at the site where arte-
riolar wall integrity is lost (6–9,32,33), 
the exact pathophysiologic importance 
of the various manifestations of the 
spot sign is not known. Our study sug-
gests that spot signs detected in earlier 
acquisitions represent active hemor-
rhaging without hemostasis and those 
observed in later acquisitions repre-
sent pools of blood accumulation that 
have been sealed off by hemostasis. 
Thus, the different patterns of spot 
sign presentation may reflect the path-
ophysiologic course of ICH expansion, 
from pattern A (with highest degree 
allow opacification of contrast material 
within the hematoma (10–12,25,30), 
our finding—that the earlier the ac-
quisition, the higher the maximum at-
tenuation of the spot sign—suggests 
otherwise. Furthermore, the different 
radiologic outcomes observed accord-
ing to the patterns of spot sign pre-
sentation support the theory that the 
underlying pathophysiology of the spot 
sign may differ according to phase pat-
tern (10,12,30,32). Conversely, radio-
logic characteristics of the spot sign 
varied across phases of multiphase CT 
angiography. However, we did not eval-
uate the influence of these differences 
or more phases of multiphase CT angi-
ography did not have it at all acquisition 
phases. This finding supports the need 
for dynamic evaluation of the spot sign 
beyond single-phase CT angiography. 
The influence of the time of imaging ac-
quisition on the prevalence of the spot 
sign observed in our study confirms the 
results of previous studies that used 
nonstandardized second-pass imaging 
(12–14,25–27).
Although previous authors have hy-
pothesized that the higher frequency 
of the spot sign being observed in later 
phases of image acquisition indicates 
that the arterial phase is too early to 
Table 2
Main Baseline Characteristics according to Inclusion in Hematoma Expansion 
Analysis
Variable
Patients Included in  
Analysis (n = 95)
Patients Not Included in  
Analysis (n = 28) P Value*
Age (y)† 70.0 6 13.8 78.6 6 10.4 .003
Men 62 (65.3) 17 (60.7) .659
Antiplatelet use 23 (24.2) 12 (42.9) .055
Anticoagulant use 15 (15.8) 6 (21.4) .486
GCS score‡ 15 (14–15) 11 (7–14) ,.001
NIHSS score‡ 13 (6–18) 19 (17–30) ,.001
Blood pressure (mm Hg)†
 Systolic 170.3 6 26.9 169.9 6 30.5 .602
 Diastolic 94.0 6 19.9 86.3 6 19.7 .987
ICH volume (mL)‡ 10.4 (5.0–28.4) 71.0 (37.1–104.2) ,.001
ICH location, lobar 24 (25.3) 14 (50.0) .013
Intraventricular extension 31 (32.6) 19 (67.9) .001
Subarachnoid extension 14 (14.7) 15 (53.6) ,.001
Spot sign in any phase 41 (43.2) 21 (75.0) .003
Note.—Except where indicated, data are numbers of patients, with percentages in parentheses. GCS = Glasgow Coma Scale; 
NIHSS = National Institutes of Health Stroke Scale.
*P values are from Pearson x2 test, Student t test, or Mann-Whitney U test as appropriate.
† Data are means 6 standard deviations.
‡ Data are medians, with IQR in parentheses. 
Table 3
Radiologic Characteristics of the Spot Sign in the Different Phases of Multiphase CT 
Angiography
Variable Phase 1 (n = 36) Phase 2 (n = 53) Phase 3 (n = 57) P Value*
Total no. of spot signs per patient 2 (1–3) 2 (1–4) 3 (1–5) ,.001
Maximum attenuation (HU) 290 (222–358) 261 (193–386) 243 (185–314) ,.001
Maximum axial diameter (mm) 4.7 (3.2–7.7) 5.0 (2.9–7.7) 5.2 (3.4–9.7) ,.001
Note.—Data are medians, with IQR in parentheses.
* Determined with the Friedman test.
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In summary, multiphase CT angi-
ography is a quick and easy-to-use tool 
for predicting hematoma expansion in 
patients with acute ICH. Multiphase 
CT angiography can help differentiate 
among different forms of spot sign pre-
sentation and can help better stratify 
patients at risk for hematoma expansion 
in different decision-making scenarios. 
It might also provide additional infor-
mation about the pathophysiology of the 
spot sign, but further studies are needed 
to elucidate the exact underlying path-
ophysiology of this imaging biomarker.
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